Medigene Ag Ord

(MDGEF)

By |

Profile

Medigene AG is a Germany based biotechnology company. Along with its subsidiaries, it is primarily engaged in developing immunotherapies to target various forms and stages of cancer with candidates in clinical and pre-clinical development. The firm is focused on the development of personalized T cell-based therapies. The operating segments of the organization are Immunotherapies. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy, DC vaccines, and T-cell-specific monoclonal antibodies. The group operates in the United States, Europe, and Other regions, of which majority of the revenue is derived from the operations in the United States.

Contact Information

Website: www.medigene.com
Email: investor@medigene.com
Main Phone: +49 892000330
Address: Lochhamer Strasse 11
City / Town: Planegg/Martinsried
Country: DEU
Postal Code: 82152

Issuer Information

Exchange: OTO
Employees: 105
$ 11.00 $ 0. (0.00%)
Last Price 11.00 Change $ 0. Change % 0.00 Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close 11.00
Last Trade Volume 0 52 Wk Hi 22.95 52 Wk Low 10.96
Market Cap 270.1 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 24,554,012.00 EPS (TTM) N/A PE Ratio N/A Exchange OTCPK